.
disclosed abnormalities suggestive of acute myocardial injury in 15 of these 23 patients. Eleven of them also showed increased LD, activity. Subendocardial haemorrhage was detected in 3 out of 8 necropsied patients with serum CK MB activity. Among those 30 patients in whom no CK MB activity was found electrocardiographic abnormalities suggestive ofacute myocardial injury were observed in 2 and increased LD, was seen in 4 cases.
The mortality was higher if either CK MB isoenzyme or electrocardiographic abnormalities suggestive of acute myocardial injury were present, compared with the patients lacking these signs (P < 0*01).
Present findings suggest that acute brain damage may secondarily cause myocardial damage more often than has been believed before. Results also indicate that a combination of acute brain damage and acute myocardial injury often indicated a poor prognosis.
Several studies suggest myocardial involvement in acute cerebral disorders. Various electrocardiographic abnormalities have been described, but signs suggestive of ischaemic myocardial injury are few (see reviews Weidler, 1974; Weintraub and McHenry, 1974) .
The lack of specificity of serum enzyme tests in confirming the myocardial damage has so far been a deterrent. Recent improvements in determination of heart type creatine kinase isoenzyme (CK MB) have made it possible to disclose myocardial damage (Roe et al., 1972; Somer and Konttinen, 1972) .
In a preliminary study concerning the release of brain type creatine kinase isoenzyme from brain to blood in acute cerebral disorders (Somer et al., 1975) we also found CK MB isoenzyme in the serum of many such patients. We, therefore, decided to study how often it can be found in various acute cerebral disorders, and whether its presence would have any prognostic significance. ' 
Patients and methods
We studied 53 patients (38 men and 15 women) with acute brain damage, between 18 and 82 years (mean 46-5 years). The diagnosis was ischaemic brain infarction in 27 cases, cerebral contusion in 10, subarachnoid haemorrhage in 8, cerebral haemorrhage in 4, bacterial meningitis in 4 cases, based on traditional clinical, laboratory, and radiological examinations. The patients showed signs of severe brain damage on admission, except those with ischaemic brain infarction. All patients were admitted for acute brain disease, not for cardiac symptoms.
Blood samples were collected on admission and daily during the first 3 hospital days, but a rigid time schedule could not always be achieved. All patients came to the hospital within 48 hours of the onset of symptoms, with the exception of 1 patient with ischaemic brain infarction and the patients with bacterial meningitis. The time from onset of symptoms to collection of first blood sample averaged 16-0 hours (SE 2-09 hours) in all but the subgroup with bacterial meningitis. In this latter group the estimation of onset was unreliable.
Total creatine kinase (CK) activity was measured 802 by using test kits (CK activated, Boehringer, Mannheim) at 25°C. The normal upper limit is 50 U/1. Creatine kinase isoenzymes were separated electrophoretically in agarose gel and determined by a fluorescence iechnique (Somer and Konttinen, 1972) .' The method does not allow detection of serum CK MB activities lower than 3 U/1.
Lactate dehydrogenase (LD) and its isoenzymes were analysed in all but 2 cases with subarachnoid haemorrhage. The upper normal limit of total LD was 204 U/1 and that of LD1 was 101 U/1, with confidence limit P< 0 01 (Konttinen et al., 1969 ( Table 4 ). The difference is significant (P <0.01). The degree of CK MB isoenzyme increase did not correlate with the mortality nor did the increase of total CK activity. The patients with electrocardiographic abnormalities suggestive of acute myocardial injury had a higher mortality (11 of 17 patients) than those without such electrocardiographic signs (8 of 32 patients) ( Table 5 ). The difference is significant (P <0.01). The increase of serum LD1 activity did not correlate with the mortality.
Discussion
Several recent studies have established the value of heart type creatine kinase isoenzyme (CK MB) as a highly heart-specific enzyme test (Konttinen and Somer, 1973; Wagner et al., 1973; Roberts and Sobel, 1976; Smith et al., 1976; Sobel et al., 1976) . In addition to myocardial injury, pathological serum CK MB activity may be found in progressive muscle dystrophies. This evidently results from an increased heart type/muscle type isoenzyme ratio in diseased muscle. Normal skeletal muscle can release excess CK in the serum, but this is muscle type isoenzyme (CK MM), not CK MB (Somer et al., 1976) . Brain type creatine kinase isoenzyme (CK BB) is also found in the serum but only transiently in severe acute brain accidents (Kaste et al., 1977 (Weidler, 1974; Weintraub and McHenry, 1974 
